Profound Medical Corp. Common Stock (PROF) News

Latest headlines that mention PROF, newest first · each headline opens the original publisher

PROF quote

Last price: $6.91
Day change: +21.65%
Next earnings: 2026-11-12

Quote & chart Expected move Insider trading IV rank history

PROF headlines

latest coverage

Investing.com 15h ago

Raymond James reiterates Strong Buy on Profound Medical stock, $11 target

General T3PROF RJF

Investing.com 1d ago

Profound Medical stock surges 20% on raised Q3 revenue outlook

Earnings T3PROF

Investing.com 1d ago

Why is Profound Medical stock surging today?

General T3PROF

Seeking Alpha 1d ago

Profound Medical expects Q3 revenue could top estimates by 47%

Earnings T2PROF

Investing.com 1mo ago

Profound Medical names Richard Fabian as president

General T3PROF

Motley Fool 1mo ago

Profound Medical (PROF) Q2 2026 Earnings Call Transcript

Record orders and expanding payer coverage mark commercial inflection.

Earnings T3PROF

Yahoo Finance 2mo ago

Profound Medical Q2 Earnings Call Highlights

Earnings T2PROF

Seeking Alpha News 2mo ago

Profound Medical Corp. (PRN:CA) Q2 2026 Earnings Call Transcript

Earnings T2PROF

Investing.com 2mo ago

Profound Medical stock upgraded to Strong Buy on trial data, reimbursement outlook

General T3PROF

Yahoo Finance 3mo ago

Profound Medical Corp. (PROF) Dropped Despite High Potential

General T2PROF

Seeking Alpha News 4mo ago

Profound Medical Corp. (PRN:CA) Shareholder/Analyst Call Prepared Remarks Transcript

General T2PROF

Yahoo Finance 5mo ago

Profound Medical Q1 Earnings Call Highlights

Earnings T2PROF

Seeking Alpha News 5mo ago

Profound Medical Corp. (PRN:CA) Q1 2026 Earnings Call Transcript

Earnings T2PROF

Investing.com 5mo ago

Earnings call transcript: Profound Medical beats Q1 2026 forecasts

Earnings T3PROF

Also mentioned with PROF

30d

RJF1

Headlines that tag both tickers

PROF news alerts

Get an alert by email or push when a new headline mentions PROF.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.